Departments & Organizations
Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal directs the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >30 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and was recently named to be a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents.
Education & Training
|MD||University of Nebraska (1988)|
|Resident||University of Nebraska College of Medicine|
|Fellow||Stanford University Medical Center|
|Board Certification||AB of Internal Medicine, Internal Medicine (1991, recertified: 2011)|